GORE EXCLUDER Conf AAA Endo - Trunk-Ipsilateral CXT201212Recalls & reported problems
W. L. Gore & Associates, Inc. · EXCLUDER CONFORM AAA TRNK ENDO 20mmX12mmX12cm 15Fr · Class 3 · Implant
All models of GORE EXCLUDER Conf AAA Endo - Trunk-Ipsilateral (10)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 6
- Deaths reported
- 1
- Injuries reported
- 5
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 6 adverse event reports that list this exact device (DI 00733132650989), received between Jul 6, 2021 and Apr 2, 2026 — classified as 1 death, 5 injuries.
The most frequently reported specific device problem is “Deformation Due to Compressive Stress” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Deformation Due to Compressive Stress2
- Adverse Event Without Identified Device or Use Problem1
- Insufficient Device Problem Information1
- Obstruction of Flow1
- Use of Device Problem1
Patient problems
- No Clinical Signs, Symptoms or Conditions2
- Aneurysm expansion1
- Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available1
- Insufficient Information1
- Obstruction/Occlusion1
Recent adverse event reports
The 6 most recent of 6 reports, in the reporter's own words as published by the FDA.
InjuryApr 2, 2026Insufficient Device Problem Information
IT WAS REPORTED THAT THE DEVICES WERE EXPLANTED DUE TO LIMB OCCLUSION, THE PATIENT PRESENTED WITH ISCHEMIA OF LOWER LIMB.
Patient problems: Insufficient Information
MAUDE report 24771888 ↗InjurySep 8, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
THE FOLLOWING WAS REPORTED TO GORE: ON (B)(6) 2022, THE PATIENT UNDERWENT AN ENDOVASCULAR PROCEDURE TO TREAT AN ABDOMINAL AORTIC ANEURYSM (AAA) UTILIZING GORE® EXCLUDER® CONFORMABLE AAA ENDOPROSTHESIS (TRUNK IPSILATERAL LEG CONFORMABLE) AND GORE® EXCLUDER® AAA ENDOPROSTHESIS (CONTRALATERAL LEG AND ILIAC EXTENDER). ON (B)(6) 2024, PATIENT PRESENTED FOR A YEARLY FOLLOW UP AFTER THE INITIAL PROCEDURE WHERE PATIENT UNDERWENT AN ABDOMINAL ULTRASOUND THAT SHOWED THE AAA HAD INCREASED IN SIZE TO 4.6 X 4.1CM FROM 4.3 X 3.8CM IN 2023 (DATE UNKNOWN). THE PATIENT IS REPORTEDLY DOING WELL WITH NO REPORTED COMPLAINTS OF ABDOMINAL OR BACK PAIN AND NO CLAUDICATION. ON (B)(6) 2025, THE PATIENT UNDERWENT AN ENDOVASCULAR REINTERVENTION PROCEDURE TO TREAT AN EXPANDING ANEURYSM (55MM) UTILIZING A GORE® EXCLUDER® CONFORMABLE AAA ENDOPROSTHESIS (AORTIC CONFORMABLE EXTENDER). REPORTEDLY, DUE TO THE PATIENT'S EXPANDING ANEURYSM (CAUSE IS UNKNOWN) WITH NO CLEAR EVIDENCE OF ENDOLEAK, PHYSICIAN DECIDED TO DO AN ELECTIVE PROCEDURE AS A PRECAUTION BY EXTENDING PROXIMALLY WITH AN AORTIC CONFORMABLE EXTENDER FROM THE TRUNK IPSILATERAL LEG CONFORMABLE. PATIENT TOLERATED THE PROCEDURE. 1001-E: -UNKNOWN IS USED TO
Patient problems: Aneurysm expansion
MAUDE report 22992644 ↗InjuryOct 9, 2024Deformation Due to Compressive Stress; Deformation Due to Compressive Stress
ON (B)(6) 2024, PATIENT UNDERWENT AN ENDOVASCULAR PROCEDURE TO TREAT A ABDOMINAL AORTIC ANEURYSM, UTILIZING GORE® EXCLUDER® CONFORMABLE AAA ENDOPROSTHESIS. ON (B)(6) 2024, DURING A FOLLOW-UP VISIT, AN ULTRASOUND WAS PERFORMED WHICH SHOWED INCREASED VELOCITIES IN LEFT LEG. A CT WAS ALSO PERFORMED, AND IT SHOWED PATIENT'S LEFT ILIAC LIMB WAS COMPRESSED, NEAR THE AORTIC BIFURCATION. PHYSICIAN RECOMMENDED A REINTERVENTION SURGERY TO TREAT THIS COMPRESSION. ON (B)(6) 2024, PATIENT UNDERWENT A REINTERVENTION SURGERY TO TREAT THIS COMPRESSION. PHYSICIAN BALLOONED THE AREA WITH 8MMX40MM BALLOON AND THEN A 10MMX40MM BALLOON. PHYSICIAN WAS SATISFIED WITH RESULTS, AND STATED HE MUST'VE NOT BALLOONED THIS AREA ENOUGH IN THE INITIAL CASE. PATIENT TOLERATED THE PROCEDURE.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 20408293 ↗InjuryMay 24, 2022Obstruction of Flow; Obstruction of Flow
ON (B)(6) 2022, THE PATIENT WAS ADMITTED FOR TREATMENT OF AN ABDOMINAL AORTIC ANEURYSM AND WAS IMPLANTED WITH A GORE® EXCLUDER® CONFORMABLE AAA ENDOPROSTHESIS TRUNK IPSILATERAL COMPONENT AND A GORE® EXCLUDER® AAA ENDOPROSTHESIS CONTRALATERAL LEG COMPONENT. OVER THE FOLLOWING WEEKEND THE PATIENT WENT TO THE EMERGENCY ROOM, AND IT WAS IDENTIFIED THAT THERE WAS AN OCCLUDED LIMB. A REINTERVENTION WAS PERFORMED ON (B)(6) 2022. THE REINTERVENTION INVOLVED A THROMBECTOMY FOLLOWED BY THE IMPLANTATION OF TWO GORE® VIABAHN® VBX BALLOON EXPANDABLE ENDOPROSTHESES AT THE AORTIC BIFURCATION VIA KISSING BALLOON TECHNIQUE IN ORDER TO PRESERVE BLOOD FLOW. AS REPORTED, THE OCCLUSION OCCURRED ON THE IPSILATERAL SIDE. THE CAUSE FOR THE NEEDED REINTERVENTION WAS DIRECTLY IDENTIFIED AS THE PATIENT ANATOMY THAT NARROWED GREATLY AROUND THE BIFURCATION. AS REPORTED THE FLOW DIVIDER WAS LATER OBSERVED TO HAVE LANDED DIRECTLY IN THE RESTRICTED AREA OF THE PATIENT¿S ANATOMY. AS REPORTED, THERE WAS NO MORE THAN APPROXIMATELY 1CM TO A 1/2CM OF SPACE IN ONE SPOT. IT WAS INDICATED THAT FOLLOWING THE INITIAL TREATMENT PROCEDURE ON (B)(6) 2022, THAT THE POST-IMPLANTATION IMAGING CONDUCTED SHOWED THAT ALL VESSELS WE
Patient problems: Obstruction/Occlusion
MAUDE report 14488357 ↗DeathAug 17, 2021Use of Device Problem; Use of Device Problem
ON (B)(6) 2021, THIS PATIENT UNDERWENT ENDOVASCULAR TREATMENT FOR AORTIC OCCLUSIVE DISEASE AND WAS IMPLANTED WITH GORE® EXCLUDER® CONFORMABLE AAA ENDOPROSTHESES. THE TRUNK IPSILATERAL LEG COMPONENT DEPLOYED CORRECTLY BUT WAS POSITIONED SLIGHTLY HIGHER THAN INTENDED WITH PARTIAL COVERAGE OF THE OSTIUM OF A RENAL ARTERY. THE DEVICE WAS RECONSTRAINED AND THE PHYSICIAN ATTEMPTED TO REPOSITION BUT STRUGGLED WITH TRYING TO REPOSITION THE CXT AND CHOSE TO LEAVE IT AS IS AND IMPLANT A GORE® VIABAHN® VBX BALLOON EXPANDABLE ENDOPROSTHESIS (VBX) COVERED STENT IN ONE OF THE RENAL ARTERIES TO ENSURE GOOD FLOW. DURING POST-DILITATION OF THE VBX WITH A CODA BALLOON CATHETER THE RENAL ARTERY WAS RUPTURED DUE TO BELIEVED OVER-INFLATION OF THE BALLOON. THE PATENT EXPIRED INTRA-PROCEDURE, A CAUSE OF DEATH WAS NOT PROVIDED.
Patient problems: Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available
MAUDE report 12334625 ↗InjuryJul 6, 2021Deformation Due to Compressive Stress; Deformation Due to Compressive Stress
ON (B)(6) 2021 THE PATIENT UNDERWENT EMERGENT ENDOVASCULAR TREATMENT OF A RUPTURED ABDOMINAL AORTIC ANEURYSM USING GORE® EXCLUDER® CONFORMABLE AAA ENDOPROSTHESES. THERE WERE NO REPORTED ISSUES. ON (B)(6) 2021 IT WAS REPORTED BY THE PHYSICIAN THAT, DURING THE ONE MONTH FOLLOW-UP ON AN UNKNOWN DATE, CT IMAGING WAS PERFORMED AND POTENTIAL DEVICE OCCLUSION WAS OBSERVED. THE CAUSE OF THE SUSPECTED DEVICE OCCLUSION WAS UNKNOWN. ON (B)(6) 2021 A REINTERVENTION WAS PERFORMED. IT WAS REPORTED THAT A SLIGHT KINK ON THE IPSILATERAL LEG OF THE TRUNK-IPSILATERAL LEG COMPONENT WAS CONFIRMED. THE IPSILATERAL LIMB WAS LOCATED ON THE PATIENT'S RIGHT SIDE. REPORTEDLY THERE WAS NO DEVICE OCCLUSION, AND DISTAL BLOOD FLOW WAS PRESENT. IT WAS REPORTED THAT THE IPSILATERAL LIMB WAS SLIGHTLY PINCHED/KINKED DUE TO PATIENT ANATOMY. REPORTEDLY THE PATIENT'S AORTA MEASURED 15MM IN DIAMETER AND HAD A LARGE ANGLE. DUE TO THE PATIENT'S ANATOMY, THE IPSILATERAL LEG OF THE TRUNK-IPSILATERAL LEG COMPONENT WAS LANDED ON THE INNER CURVE OF THE PATIENT'S AORTA, THUS CAUSING A SLIGHT KINK. THERE WERE NO PATIENT ADVERSE EVENTS NOTED IN RELATION TO THE KINKED IPSILATERAL LIMB. A GORE® VIABAHN® VBX BALLOON EXPANDABLE ENDO
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 12125098 ↗
Other System, Endovascular Graft, Aortic Aneurysm Treatment devices
- Endurant® IIs ESBF2814C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls34 deaths254 reports
- Endurant® IIs ESBF3214C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls19 deaths173 reports
- Endurant® IIs ESBF3614C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT1 recall37 deaths214 reports
- Endurant® IIs ESBF2514C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls18 deaths136 reports
- Endurant® IIs ESBF2314C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls9 deaths60 reports
- RelayPro Thoracic Stent-Graft System 28-N4-34-154-34UBolton Medical Inc. · System, Endovascular Graft, Aortic Aneurysm Treatment3 recalls7 reports
- Vela Proximal Endograft System A34-34/C100-O20 VEndologix LLC · System, Endovascular Graft, Aortic Aneurysm Treatment3 deaths152 reports
- Endurant® II ETCF2828C49EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls7 deaths44 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page